HILARY PUZAK: Open Payments
NPI 1659004927 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 68 payments from 16 companies in 2025. Trend: 2023 $462 · 2024 $576 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $223 |
| Janssen Pharmaceuticals, Inc | 8 | $167 |
| ABBVIE INC. | 14 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $117 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Lundbeck LLC | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, REJOYN, AUSTEDO XR, SPRAVATO, Auvelity.
Industry payments across NC — which companies pay providers there.
